Get started
DAEBONGLS CO., LTDDD

DAEBONGLS CO., LTD

13,780KRWD
−280−1.99%
At close at 09:08 GMT
KRW
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

078140 fundamentals

Key facts

Market capitalization‪153.93 B‬KRW
Dividend yield (indicated)0.36%
Price to earnings Ratio (TTM)16.93
Basic EPS (TTM)830.66KRW
Founded1986
Employees (FY)138
CEO—
Websitedaebongls.co.kr
About

DaebongLS Co., Ltd. engages in the manufacturing and distribution of raw materials for pharmaceuticals and cosmetics. It operates through the Raw Pharmaceuticals Products and Cosmetics Materials business division. The Raw Pharmaceuticals Products business division offers respiratory medicine, high blood pressure medicine, digestive medicine, etc. The Cosmetics Materials business division covers the functional cosmetic materials using natural materials and fusion synthesis. The company was founded by Jong-Ho Park on July 8, 1986 and is headquartered in Incheon, South Korea.

Ownership
‪‪10.95 M‬‬
Closely held shares
‪‪5.71 M‬‬ (52.14%)
Free Float shares
‪‪5.24 M‬‬ (47.86%)
Closely held shares
‪‪5.71 M‬‬ (52.14%)
Free Float shares
‪‪5.24 M‬‬ (47.86%)
Capital structure
Market cap
‪‪153.93 B‬‬
Debt
‪‪54.77 B‬‬
Minority interest
‪‪32.78 B‬‬
Cash & equivalents
‪‪55.33 B‬‬
Enterprise value
‪‪186.15 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪153.93 B‬‬
Price to earning ratio (P/E)
16.93x
Price to sales ratio (P/S)
1.59x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
16.93x
Price to sales ratio (P/S)
1.59x
Valuation ratios
‪0.00‬
‪0.70‬
‪1.40‬
‪2.10‬
‪2.80‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪8.00‬
‪16.00‬
‪24.00‬
‪32.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−9%‬
‪0%‬
‪9%‬
‪18%‬
‪27%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−9.00 B‬‬
‪0.00‬
‪‪9.00 B‬‬
‪‪18.00 B‬‬
‪‪27.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪7.00 B‬‬
‪‪14.00 B‬‬
‪‪21.00 B‬‬
‪‪28.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪7.00 B‬‬
‪‪14.00 B‬‬
‪‪21.00 B‬‬
‪‪28.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Manufacturing
Research
Wholesale
By country
Period: 2024
South Korea
International

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
2018
2019
2021
2022
‪0.00‬
‪‪25.00 B‬‬
‪‪50.00 B‬‬
‪‪75.00 B‬‬
‪‪100.00 B‬‬
Actual
Estimate
Earnings
Next:—
2018
2019
2021
2022
‪0.00‬
‪250.00‬
‪500.00‬
‪750.00‬
‪‪1.00 K‬‬
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
6.02%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.36%
Last payment
50.00
Last ex-date
Dec 27, 2024
Last pay date
Apr 24, 2025
Dividend history
‪0.35%‬
‪0.42%‬
‪0.49%‬
‪0.56%‬
‪0.63%‬
2020
2021
2022
2023
2024
‪0.00‬
‪13.00‬
‪26.00‬
‪39.00‬
‪52.00‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−20.00 B‬‬
‪0.00‬
‪‪20.00 B‬‬
‪‪40.00 B‬‬
‪‪60.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪35.00 B‬‬
‪‪70.00 B‬‬
‪‪105.00 B‬‬
‪‪140.00 B‬‬
Assets
Liabilities